CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 20 enrolled
Drug / intervention
Chlorhexidine gluconatedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02513784
NCT02513784N/ACompleted
CompareCT.gov

Pilot Randomized Trial to Assess the Effects of an Antimicrobial Mouthwash on the Esophageal and Gastric Microbiome

Columbia University·interventional·Posted Aug 3, 2015·Updated Sep 22, 2022

In Brief

A clinical study evaluating Chlorhexidine gluconate for Esophageal Adenocarcinoma and 2 related conditions. Completed, enrolled 20 participants across 1 site.

Detailed Summary

This is a randomized, open-label pilot study to assess whether treatment with chlorhexidine mouthwash can alter the esophageal and gastric cardia microbiome

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEsophageal Adenocarcinoma, Barrett's Esophagus, Reflux Esophagitis
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedAug 3, 2015
Enrollment StartAug 1, 2015
Primary CompletionDec 1, 2017
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 10.9 years ago

Interventions

Chlorhexidine gluconatedrug

Chlorhexidine gluconate is a germicidal mouthwash that reduces bacteria in the mouth.